tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aquestive Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsAquestive Therapeutics Reports Q2 2025 Financial Results
13d ago
Aquestive Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Aquestive Therapeutics Reports Q2 2025 Financial Results
14d ago
AQST Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AQST Earnings this Week: How Will it Perform?
17d ago
Positive Outlook for Aquestive Therapeutics Amidst FDA Progress and Strategic Preparations for Anaphylm Launch
PremiumRatingsPositive Outlook for Aquestive Therapeutics Amidst FDA Progress and Strategic Preparations for Anaphylm Launch
2M ago
Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s FDA Progress and Market Potential
Premium
Ratings
Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s FDA Progress and Market Potential
2M ago
FDA Accepts Aquestive’s New Drug Application for Anaphylm
Premium
Company Announcements
FDA Accepts Aquestive’s New Drug Application for Anaphylm
2M ago
Aquestive Therapeutics price target lowered to $7 from $15 at Oppenheimer
PremiumThe FlyAquestive Therapeutics price target lowered to $7 from $15 at Oppenheimer
3M ago
Aquestive Therapeutics’ Earnings Call: Mixed Outlook
Premium
Company Announcements
Aquestive Therapeutics’ Earnings Call: Mixed Outlook
3M ago
Buy Recommendation for Aquestive Therapeutics: Promising Prospects for Anaphylm’s Market Launch and Growth
Premium
Ratings
Buy Recommendation for Aquestive Therapeutics: Promising Prospects for Anaphylm’s Market Launch and Growth
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100